Skip to content

Medifast MED Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
Lifevantage Corporation logo
Lifevantage CorporationLFVN

Other financials

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation

See full
Market cap$121.87M-17.4%
Enterprise value$66.44M+12.8%
P/S0.4×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp
FCF margin5%-9.3pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medifast's common stock, shares issued (in shares)?
Medifast (MED) reported common stock, shares issued (in shares) of $11.12M in Q1 2026.
How has Medifast's common stock, shares issued (in shares) changed year-over-year?
Medifast's common stock, shares issued (in shares) increased by 1.2% year-over-year, from $10.99M to $11.12M.
What is the long-term trend for Medifast's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Medifast's common stock, shares issued (in shares) has grown at a -1.4% compound annual growth rate (CAGR), from $11.82M to $10.99M.